Laparoscopic treatment of recurrent small bowel obstruction secondary to ileal endometriosis.

(Kerin- Orbuch I, Riech H, Orbuch M, Orbuch

L. J of Minimally Invasive Gynecology. 2007 January (14:1); 133-115.)

 

Optimizing outcomes in acute pancreatitis.

(Orbuch M. In: Clinics of North America: PrimaryCare Clinics in Office Practice. Edited by Joel Heidelbaugh; September 2004.)

 

Yield of screening sigmoidoscopy in Puerto Rican born immigrants to the mainland United States (abstract).

(Gaddipati K, Orbuch M, Weiss A. Am J Gastro. 2000 September(95:9); 2534.)

 

Considerations in the abdominal examination.

(Orbuch M, Dunn AS. In: Infectious Diseases in Critical Care Medicine. Edited by Burke Cunha; Marcel Dekker, Co., New York. 1998)

 

Imaging for pancreatic endocrine tumor localization: recent advances.

(Orbuch M, Doppman JL, et al. In: Endocrine tumors of the pancreas: recent advances.Edited by Michel Mignon and Robert T. Jensen. Frontiers of Gastrointestinal Research, Karger Publishing Ag., Basel, Switzerland; vol 23. 1996)

 

Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger Ellison syndrome.

(Orbuch M, Venzon DJ, Lubensky IA, Weber HC, et al. Dig Dis Sci. 1996 March; 41(3): 604-13)

 

Functional localization of enteropancreatic neuroendocrine tumors.

(DB Strader JL Dopmann, M Orbuch, et al. In: Endoctine tumors of the pancreas: recent advances. Edited by Michel Mignon and Robert T. Jensen. Frontiers of Gastrointestinal Research; Karger Publishing Ag., Basel, Switzerland. vol 23. 1996)

 

Esophageal function and occurance of Barrettʼs esophagus in Zollinger-Ellison syndrome.

(Strader DB, Benjamin SB, Orbuch M, et al. Esophageal function and occurance of Barrettʼs esophagus in Zollinger-Ellison syndrome. Digestion. 1995; 56(5): 347-56)

 

Localization of pancreatic endocrine tumors.

(Orbuch M, Doppman JL, Jensen RT. Seminars in Gastrointestinal Disease. Edited by Marvin H Sleisinger and John S Fordtran. WB Saunders Publishing Co.; Duluth, MN. 1995 April 6(2): 90-101)

 

Diagnosis and management of Zollinger-Ellison syndrome.

(Weber HC, Orbuch M, Jensen RT. Seminars in Gastrointestinal Disease. Edited by Marvin H Sleisinger and John S Fordtran. WB Saunders Publishing Co.; Duluth, MN. 1995 April 6(2): 79-89)

 

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study.

(Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, et al. Gastroenterology. 1995 Jun; 108(6): 1637-44)

 

A reversible cause of hypergastrinemia and hyperchlorhydria which may mimic Zollinger Ellisonsyndrome.

(Metz DC,Weber HC, Orbuch M, et al. Helicobacter pylori infection. Dig Dis Sci. 1995 Jan; 40(1): 153-9)

 

Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I.

(Benya RV, Metz DC, Venzon DJ, Fishbeyn VA, Strader DB, Orbuch M, Jensen RT. Am J Med. 1994 Nov; 97(5): 436-44)

 

Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.

(Metz DC, Strader DB, Orbuch M, Koviack PD, Feigenbaum KM, Jensen RT. Aliment Pharmacol Ther. 1993 Dec; 7(6): 597-610)

 

An evaluation human recombinant alpha interferon in patients with metastatic gastrinoma.

(Pisegna JR, Slimak GG, Doppman JL, Strader DB, Metz DC, Benya RV, Orbuch M,et al. Gastroenterology. 1993 Oct; 105(4): 1179-83)

Discovery of a new class of neuromedin B receptor antagonists: substituted somatostatin analogues.

(Orbuch M, Taylor JE, et al. Mol Pharmacol. 1993 Oct; 44(4): 841-50)

 

Prospective study of the need for long-term antisecretory therapy in patients with Zollinger-Ellison syndrome following successful curative gastrinoma resection.

(Metz DC, Benya RV, Fishbeyn VA, Pisegna JR, Orbuch M, et al. Aliment Pharmacol Ther. 1993 Jun; 7(3): 247-257)